Viewing Study NCT02632903


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2025-12-29 @ 7:13 PM
Study NCT ID: NCT02632903
Status: WITHDRAWN
Last Update Posted: 2018-08-22
First Post: 2015-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
Sponsor: Children's Hospital of Eastern Ontario
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10
Start Date Type: None
Primary Completion Date: 2018-03
Primary Completion Date Type: ESTIMATED
Completion Date: 2018-08-20
Completion Date Type: ACTUAL
First Submit Date: 2015-12-15
First Submit QC Date: None
Study First Post Date: 2015-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-08-20
Last Update Post Date: 2018-08-22
Last Update Post Date Type: ACTUAL